Insider Trading: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

33.01USD
21 May 2013
Price Change (% chg)

$-0.05 (-0.15%)
Prev Close
$32.93
Open
$33.20
Day's High
$33.49
Day's Low
$33.00
Volume
892,815
Avg. Vol
1,166,978
52-wk High
$34.70
52-wk Low
$22.02

Search Stocks
MARSH RICHARD M Options Exercised: 0
Trade Date: Monday, 6 Feb 2012 Price: 5.89
Title: General Counsel Shares Held: 14,005
Type Traded: Direct Net Change in Shares This Filing: -7,667
» More Insider Trading

Institutional Holders

% Shares Owned: 95.55%
# of Holders: 315
Total Shares Held: 76,110,212
3 Mo. Net Change: -1,590,778
# New Positions: 36
# Closed Positions: 54
# Increased Positions: 142
# Reduced Positions: 163
# Net Buyers: -21

Officers & Directors

Name Age Since Current Position

John Henderson

 2005 Independent Chairman of the Board

Peter Meldrum

 65 1991 President, Chief Executive Officer, Director

Walter Gilbert

 80 Independent Vice Chairman of the Board

James Evans

 49 2007 Chief Financial Officer, Treasurer

T. Craig Benson

 50 2011 President of Myriad RBM, Inc.

Mark Capone

 50 2010 President of Myriad Genetic Laboratories, Inc.

Richard Marsh

 54 2005 Executive Vice President, General Counsel, Secretary

Jayne Hart

 52 2011 Executive Vice President - Human Resources

Gary King

 56 2010 Executive Vice President - International Operations

Robert Harrison

 46 2008 Chief Information Officer

Jerry Lanchbury

 53 2010 Chief Scientific Officer

Lawrence Best

 2009 Independent Director

Heiner Dreismann

 59 2010 Independent Director

Dennis Langer

 2004 Independent Director

S. Louise Phanstiel

 54 2009 Independent Director
Search Stocks